Quantcast

Latest Peptides Stories

2010-02-24 11:19:33

Efficient identification of drug candidates The search for new therapeutic agents is time-consuming and expensive. Pharmaceutical companies may have to screen thousands of compounds for the ability to bind a target molecule before they hit upon a promising drug candidate. A group of Biophysicists at LMU Munich led by Professor Dieter Braun, a member of the Cluster of Excellence "Nanosystems Initiative Munich" (NIM), and a partner in NanoTemper (an LMU spin-off), have now developed a unique...

2010-02-11 09:00:00

NEW YORK, Feb. 11 /PRNewswire/ -- A clinical study by Dr. Jay Hoffman, PhD, professor and chair of the Department of Health and Exercise Science at the College of New Jersey, has shown Sustamine(TM) L-Alanyl-L-Glutamine, increases performance in endurance exercise and activity. The study was published on February 3, 2010, in the Journal of the International Society of Sports Nutrition (JISSN), a peer-reviewed journal covering various aspects of sports nutrition, supplementation, exercise...

2010-01-26 14:00:00

SALEM, N.H., Jan. 26 /PRNewswire/ -- ALPCO Diagnostics has developed two new low-sample volume ELISAs for the quantitative analysis of total proinsulin (I and II) in rats and mice. These methods were developed using synthetic rat and mouse proinsulin I and II expressed in bacteria and purified from inclusion bodies, and were first introduced in an abstract presented at the Upper Midwest Islet Club Meeting in June 2009. Both the Rat Proinsulin ELISA and Mouse Proinsulin ELISA allow for the...

0e39dc76d44586763572be7a922d77071
2010-01-10 12:15:00

A strip of paper infused with carbon nanotubes can quickly and inexpensively detect a toxin produced by algae in drinking water. Engineers at the University of Michigan led the development of the new biosensor. The paper strips perform 28 times faster than the complicated method most commonly used today to detect microcystin-LR, a chemical compound produced by cyanobacteria, or blue-green algae. Cyanobacteria is commonly found on nutrient-rich waters. Microcystin-LR (MC-LR), even in very...

2009-12-17 09:17:00

BASKING RIDGE, N.J., Dec. 17 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, today announced the completion of a $40 million Series D financing. The round, led by new investor Edmond de Rothschild Investment Partners, part of The LCF Rothschild Group, was joined by existing investors Domain Associates, Quaker Bioventures, Aurora Funds, Caxton Advantage Life Sciences Fund and other...

2009-12-09 14:04:32

Approximately 20 percent of dialysis patients undergoing a percutaneous coronary intervention (PCI; procedure such as angioplasty) are given an antithrombotic medication they should not receive, which may increase their risk for in-hospital bleeding, according to a study in the December 9 issue of JAMA. "In the United States, medication errors are implicated in more than 100,000 deaths annually. Medication errors include adverse drug reactions related to inappropriately prescribed or...

2009-12-07 09:00:00

NEW YORK, Dec. 7 /PRNewswire/ -- In an effort to heighten awareness and further educate the medical community about the importance of glutathione, Kyowa Hakko USA is sponsoring a special glutathione workshop entitled, Absorption of Oral Glutathione and Implications for Human Health, at the 17th Annual World Congress on Anti-Aging Medicine (A4M) in Las Vegas, Thursday, December 10, 6-8 p.m. in the South Pacific Ballroom I at the Mandalay Bay Resort and Convention Center. To RSVP for the free...

2009-11-30 15:19:56

Finding and treating a tumor without disturbing normal tissue presents challenges "“ sometimes the most effective therapies can be invasive and harsh. Researchers at Duke University Medical Center have devised a way they might deliver the right therapy directly to tumors using special molecules, called aptamers, which specifically bind to living tumor tissue. They screened a large pool of aptamers in a rodent with liver cancer until they found the best molecule to bind to a tumor...

2009-11-25 09:21:00

BASKING RIDGE, N.J., Nov. 25 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David Mazzo, PhD, CEO and President, will be presenting at the Piper Jaffray 21st Annual Health Care Conference at the New York Palace Hotel in New York City. Dr. Mazzo's presentation will be given at 1:10pm (EST) on Tuesday, December 1 and will include an overview of the Company's pipeline with emphasis on...

2009-11-12 08:36:00

BASKING RIDGE, N.J., Nov. 12 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David Mazzo, PhD, CEO and President, will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference at the St. Regis Hotel in New York City. Dr. Mazzo's presentation will be given at 1:10pm (EST) on Tuesday, November 17 and will include an overview of the Company's pipeline with emphasis on...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related